Frederic Ors BS Of IMV, Inc. Discusses DeCidE1 study: Looking At Tumor Aggression After Treatment, Up To 30 Month Clinical Response.
Advertisement
DeCidE1 study: Looking At Tumor Aggression After Treatment, Up To 30 Month Clinical Response
By Editor